Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Employment income groups by place of work status: Canada, provinces and territories, census divisions and census subdivisions of work
- Merchandise imports and exports, customs-based, by free trade agreement and by commodity, inactive
- Canadian international merchandise trade by province and country, and by product sections, customs-based, annual, inactive
- Canadian international merchandise trade by principal trading partner, and by product section and group, customs-based, annual, inactive
- Canadian international merchandise trade by country and by product section, customs-based, annual, inactive
- International merchandise trade, by commodity, price and volume indexes, monthly, inactive
- International merchandise trade, by commodity, price and volume indexes, annual, inactive
- International merchandise trade, by commodity, price and volume indexes, quarterly, inactive
- International merchandise trade by commodity, chained 2012 dollars, quarterly, inactive
- International merchandise trade by commodity, chained 2012 dollars, monthly, inactive
- International merchandise trade by commodity, quarterly, inactive
- International merchandise trade by province, commodity, and Principal Trading Partners, inactive
- Mother tongue by language spoken most often at home for children in couple families: Canada, provinces and territories and census metropolitan areas with parts
- Housing suitability by tenure, with household type including census family structure: Canada, provinces and territories, census divisions and census subdivisions
- Employment income groups by place of work status: Census metropolitan areas, tracted census agglomerations and census tracts
- Commuting flow from geography of residence to geography of work by main mode of commuting, commuting duration and gender: Census metropolitan areas and census agglomerations
- 2023-12-04 Recommendations recommandations
- Central Business District Cordon Count 2023
- Clinical Development of Steroidal Contraceptives Used by Women
- Guidelines for the Toxicological Evaluation of Contraceptive Steroids
- Safety Pharmacology Studies for Human Pharmaceuticals ICH Topic S7A
- Basic Product Monograph Information for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Canada’s regulatory approach to drugs for rare diseases: orphan drugs
- Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials
- Canada’s regulatory approach to drugs for rare diseases: find clinical trials
- Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions
- Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients
- Clinical trials and special access programs
- Clinical Trials: Registration and Disclosure of Information
- Drug and medical device approval overview
- Drug/Medical Device Combination Products
- Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry
- Final Notice: Classification of Dental Plaque-Disclosing Products as Drugs
- Guidance Document - Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure and Format of Qualification Submissions ICH Topic E16
- Administration of the Access to Information Act - Annual Report to Parliament 2022-2023
- Notice: Health Canada’s Approach to Digital Health Technologies
- Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health Products
- Notice: Improving access to medical devices information
- Guidance Document - Certificates of Supplementary Protection
- Guidance Document - E10: Choice of Control Group and Related Issues in Clinical Trials
- Guidance Document - Ethnic Factors in the Acceptability of Foreign Clinical Data ICH Topic E5(R1)
- Guidance Document - Guidance for Manufacturers of Human Immunodeficiency Virus (HIV) Rapid Diagnostic Tests (RDTs) for use at the Point of Care or for Self-Testing
- Administration of the Privacy Act - Annual Report to Parliament 2022-2023
- Guidance Document - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Impurities in New Drug Substances - ICH Topic Q3A(R2)
- Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)
- Guidance Document: Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma
- Health Canada's Clinical Trials Database
- Health Canada's special access programs: Overview
- Health Canada's special access programs: Request a drug
- Guidance Document: Tamper-resistance Formulations of Opioid Drug Products